Alle Studien
Aktiv, aber nicht rekrutierendPHASE3INTERVENTIONELL

Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria

This study is for young people aged 12 to 17 who have a condition called Phenylketonuria, or PKU. PKU means your body has trouble breaking down a substance called phenylalanine, which can cause health problems. The study is testing a new injectable medicine called pegvaliase to see if it helps manage PKU better than just a special diet alone. Some participants will receive the pegvaliase injection, and others will continue with their usual PKU diet. Researchers want to find out if this new treatment is both safe and effective in controlling phenylalanine levels in the blood. If you or a teenager you know has PKU and might be interested, reading the full details will help you understand more.

Auf einen Blick

Status
Aktiv, aber nicht rekrutierend
Phase
PHASE3
Sponsor
BioMarin Pharmazeutik
Einschreibeziel
55
Starten
17 Jun 2022
Geschätzte Fertigstellung
01 Okt 2027

Worum geht es in dieser Studie?

Phenylketonuria, or PKU, is a rare condition that babies are usually tested for at birth. If you have PKU, your body can't properly break down an important part of food called phenylalanine. When too much phenylalanine builds up in the blood, it can cause health problems. People with PKU typically need to follow a very strict diet throughout their lives to keep their phenylalanine levels under control, and sometimes they also take other medicines.

This study, called a Phase 3 study, is looking at a new medicine called pegvaliase. Researchers want to see if this medicine, given as an injection, can help teenagers aged 12 to 17 who have PKU. It's for those whose phenylalanine levels are still too high, even with their current treatment which usually involves a special diet. The goal is to find out if pegvaliase is safe and if it helps to lower and control phenylalanine levels better than just relying on diet alone.

In this study, some teenagers will receive the pegvaliase injection every day, while others will continue to manage their PKU using only their special diet. By comparing these two groups, the researchers hope to understand if pegvaliase can offer a new and effective way to help young people with PKU live healthier lives.

Wichtige Erkenntnisse

  • This study is testing a new injection (pegvaliase) for teenagers with PKU.
  • It aims to see if pegvaliase is safe and effective in lowering high phenylalanine levels.
  • Participants will either receive the injection or continue with their special PKU diet.
  • A parent or guardian adult must help with injections and monitoring.
  • The study involves regular clinic visits for checks and blood tests.
  • Die Teilnahme ist freiwillig, und Sie können jederzeit zurücktreten.

Wer könnte berechtigt sein?

This study is looking for teenagers aged 12 to 17 (in the UK, this is usually up to 15 for some aspects) who have been diagnosed with PKU. It's important that your current treatment, even if it includes special diets or other medicines, hasn't been able to consistently keep your blood phenylalanine levels low enough. Specifically, your levels need to have been above 600 μmol/L on a couple of recent tests, and generally high over the last year.

You and your family must be willing to work closely with a study dietitian to stick to the special diet required by the study. If you take medication for conditions like ADHD or depression, you need to have been on a stable dose for at least 8 weeks before joining. Also, an adult aged 18 or over must be available and willing to help you with the daily injection and watch you for about an hour afterwards.

There are also some reasons you wouldn't be able to join. For example, if you've ever had pegvaliase before. You also can't be taking any other PKU medicines, or certain types of injectable drugs that contain a substance called polyethylene glycol (PEG), within a specific time before or during the study, unless it's for something like contraception that's been discussed with the study team.

Könnte diese Studie für Sie geeignet sein?

Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.

  1. Are you between 12 and 17 years old?
  2. Do you have PKU, and your phenylalanine levels are often too high?
  3. Are you willing to follow a special diet guided by a dietitian?
  4. Is there an adult (18+) who can help you with daily injections and watch you afterwards?
  5. Have you *not* had pegvaliase treatment before?
  6. Are you able to avoid other specific PKU medicines during the study?
Beantworten Sie jede Frage, um Ihr Ergebnis zu sehen.

Was beinhaltet die Teilnahme?

If you decide to take part in this study, you'll first have a screening period to make sure you're a good fit. During the study, you would be randomly placed into one of two groups: either you'll receive the pegvaliase injection every day, or you'll continue to manage your PKU with your special diet alone. You won't get to choose which group you're in, as this helps make the study fair.

The pegvaliase is given as a daily injection. An adult will need to be present to help you with this and to watch you for about an hour afterwards for any reactions. You'll also work closely with a study dietitian to manage your food intake according to the study's plan. Throughout the study, you'll have regular appointments at the clinic for assessments, which will include blood tests to check your phenylalanine levels and monitor your general health. These visits will help the doctors see how you are doing and if the treatment is working. The total duration of the study would be discussed in detail by the study team, including how long you would be receiving the study treatment and how often you'd need to visit the clinic.

Potenzielle Risiken und Vorteile

Taking part in any study has potential benefits and risks. A potential benefit of this study is that the pegvaliase injection might help to lower your phenylalanine levels more effectively than your current treatment, which could improve your health and quality of life. However, it's also possible that the treatment might not work for you, or it could cause side effects. Like all medicines, pegvaliase might have some side effects, which you would be fully informed about before deciding to join. The study team will carefully monitor you for any problems. Remember, taking part is completely voluntary, and you are free to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Standorte (16)

  • Phoenix Kinderkrankenhaus
    Verifizierte Postleitzahl
    Phoenix, Vereinigte Staaten
  • Arkansas Children's Hospital
    Verifizierte Postleitzahl
    Little Rock, Vereinigte Staaten
  • Children's Hospital of Colorado
    Verifizierte Postleitzahl
    Aurora, Vereinigte Staaten
  • University of South Florida
    Verifizierte Postleitzahl
    Tampa, Vereinigte Staaten
  • Ann and Robert H. Lurie Children's Hospital of Chicago
    Verifizierte Postleitzahl
    Chicago, Vereinigte Staaten
  • IU Health University Hospital
    Verifizierte Postleitzahl
    Indianapolis, Vereinigte Staaten
  • University of Kentucky College of Medicine
    Verifizierte Postleitzahl
    Lexington, Vereinigte Staaten
  • Boston Kinderkrankenhaus
    Verifizierte Postleitzahl
    Boston, Vereinigte Staaten
  • University of Pittsburgh Medical Center
    Verifizierte Postleitzahl
    Pittsburgh, United States
  • McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth)
    Verifizierte Postleitzahl
    Houston, Vereinigte Staaten
  • University of Utah Medical Center
    Verifizierte Postleitzahl
    Salt Lake City, Vereinigte Staaten
  • University of Virginia School of Medicine
    Verifizierte Postleitzahl
    Charlottesville, United States

Häufige Fragen

What is PKU?

PKU, or Phenylketonuria, is a condition where your body can't properly break down a substance called phenylalanine found in food. This can lead to health problems if not controlled.

What is pegvaliase?

Pegvaliase is a new medicine, given as an injection, that researchers are testing to help people with PKU manage their phenylalanine levels.

Wie lange wird die Studie dauern?

The full duration of the study, including initial screening, treatment period, and follow-up, will be clearly explained by the study team if you are suitable to participate.

Muss ich bezahlen, um an der Studie teilzunehmen?

No, you will not have to pay to participate in the study. All study-related care and medication will be provided by the study.

Kann ich die Studie verlassen, wenn ich meine Meinung ändere?

Yes, you can choose to leave the study at any time, for any reason, without it affecting your usual medical care.

Wie Sie mehr erfahren können

Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.

Diskussion

Community-Diskussion

Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.